betaloc zok 50 toimeainet prolongeeritult vabastav tablett
recordati ireland limited - metoprolool - toimeainet prolongeeritult vabastav tablett - 50mg 100tk; 50mg 30tk; 50mg 28tk; 50mg 98tk
alkeran süstelahuse pulber ja lahusti
aspen pharma trading limited - melfalaan - süstelahuse pulber ja lahusti - 50mg 1tk
betaloc zok 100 toimeainet prolongeeritult vabastav tablett
recordati ireland limited - metoprolool - toimeainet prolongeeritult vabastav tablett - 100mg 30tk; 100mg 100tk; 100mg 28tk; 100mg 98tk
tracrium süste-/infusioonilahus
aspen pharma trading limited - atrakuuriumbesilaat - süste-/infusioonilahus - 10mg 1ml 5ml 5tk; 10mg 1ml 2.5ml 5tk
zantac süste-/infusioonilahus
glaxosmithkline (ireland) limited - ranitidiin - süste-/infusioonilahus - 25mg 1ml 2ml 5tk
imigran ninasprei, lahus
glaxo wellcome uk limited trading as glaxo wellcome operations - sumatriptaan - ninasprei, lahus - 20mg 1annus 1tk
betaloc zok 25 toimeainet prolongeeritult vabastav tablett
recordati ireland limited - metoprolool - toimeainet prolongeeritult vabastav tablett - 25mg 28tk; 25mg 14tk; 25mg 98tk
zovirax i.v. infusioonilahuse pulber
glaxosmithkline (ireland) limited - atsikloviir - infusioonilahuse pulber - 250mg 5tk
flolan infusioonilahuse pulber ja lahusti
glaxosmithkline (ireland) limited - epoprostenool - infusioonilahuse pulber ja lahusti - 0,5mg 1tk
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - mitu müeloomit - antineoplastilised ained - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.